005.01 Healthcare
Providers
1-005.01A
Immediate
Reports of Diseases, Poisonings and Organisms: Healthcare
providers must report diseases, poisonings and organisms, listed in 173 NAC
1-004.01A, by
telephone, facsimile or other secure electronic mail system within 24 hours of
diagnosis or detection. Reports must include the information as
specified in
1-005.01D.
See 173 NAC
1-006, Where to Report.
1-005.01B
Immediate Reports of
Clusters, Outbreaks, or Unusual Events, Including Possible Bioterroristic
Attacks: Healthcare providers must report by telephone, facsimile,
or other secure electronic mail system, information relating to confirmed,
diagnosed, detected, or suspected clusters, outbreaks, or epidemics of any
health problem, infectious or other, both in the community and in
healthcare settings, including food poisoning, influenza or
possible bioterroristic attack; increased disease incidence beyond
expectations; unexplained deaths possibly due to infectious causes; any unusual
disease or manifestations of illness. Reports must include the
information as specified in
1-005.01D.
See 173 NAC
1-006, Where to Report.
1-005.01C
Reports Within Seven
Days: Healthcare providers must make reports of diseases,
poisonings and organisms listed in 173 NAC 1-004.02, within seven days of
diagnosis or detection.
1-005.01C1
Reports may be made by postal service, telephone, facsimile,
electronic laboratory report, or other secure electronic mail system and must
include the information as specified in
1-005.01D.
1-005.01C2 AIDS and HIV disease reports may
be made by postal service, telephone, facsimile
, electronic
laboratory report, or other secure electronic mail system,
submitted on or including the same information as Attachment A.
Adult cases of AIDS and HIV disease (patients
> 13 years of age at time of diagnosis) must be
submitted on or include the same information in the Adult HIV
Confidential Case Report Form as described in 173 NAC
1-002. Pediatric cases of
AIDS and HIV disease (patients < 13 years of age at time of diagnosis) and
perinatally exposed HIV cases must be submitted on or include the same
information in the Pediatric HIV Confidential Case Report Form,
described in 173 NAC
1-002. AIDS and HIV case
reports are required from healthcare providers
responsible for:
1. Treating or
diagnosing a person with HIV-1 or HIV-2 disease, based on the laboratory tests
listed in 173 NAC 1-005.02B3a1 as being definitive for HIV infection, or based
on clinical criteria, as outlined in the CDC's most
recent case definition for HIV;
2.
Treating or diagnosing a person with AIDS as outlined in CDC's most recent case
definition for AIDS;
3. Providing
medical care to a pregnant woman with HIV disease;
4. Providing medical care to a baby under 19
months of age born to a woman with HIV disease (perinatally HIV exposed). The
diagnosis of HIV infection or determination of no infection is determined by
CDC's most recent case definition for HIV; and
5. Treating or diagnosing potential cases of
public health importance related to HIV infection including:
a. Unusual strains of HIV (HIV-2 or non-B
subtype of HIV-1); and
b. Unusual
modes of transmission (such as, but not limited to transplant or artificial
insemination; transfusion of blood or blood components, child sexual abuse,
occupational, household, or other unusual exposure).
1-005.01C3
Reporting
of Tuberculosis: Healthcare providers must report positive
tuberculosis diagnostic tests (culture and nucleic
acid amplification) or positive histological evidence indicative of
tuberculosis infection or disease.
1-005.01D
Report Information:
Reports made under 1-005.01 must contain the following
information:1.
Patient first and last name;
2.
Patient address including
street, city, and zip;
3.
Patient date of
birth;
4.
Patient gender;
5.
Patient race and ethnicity (if
available);
6.
Patient occupation (if available);
7.
Patient pregnancy status (if
available);
8.
Date of report;
9.
Physician
name;
10.
Physician address and telephone number;
11.
Name of hospital or clinic
(if any)
12.
Date and time of onset (if available);
13.
Date of diagnosis (if
available);
14.
Mode of transmission (if available);
15.
Date of specimen
collection;
16.
Specimen source;
17.
If lead test, whether sample
is a capillary or venous blood sample;
18.
Ordered
tests;
19.
Laboratory findings or result;
20.
Other information pertinent
to the case as requested.
1-005.01E
Reporting to
Laboratories: For all laboratory tests which may identify a
reportable disease (e.g. microbiology tests, hepatitis tests, etc.) and which
are ordered through submission of an electronic requisition or other automated
electronic mechanism, providers must include the information as
specified in 173 NAC
1-005.02B4 (except
laboratory findings or result) at the time the test order is
placed to the laboratory so that the laboratory may fulfill reporting
requirements .
005.02 Laboratories
1-005.02A
Electronic
Reporting:
All laboratories performing
clinical testing on Nebraska residents must electronically report laboratory
test results for the diseases specified in 173 NAC
1-004 and the tests specified in
1-005.02. This may be accomplished
either through manual online data entry into Nebraska's electronic disease
reporting system, or through automated electronic laboratory reporting. Paper
reports will be accepted only when established electronic transmission methods
are inoperable.
1-005.02B
Laboratories Using NEDSS Manual Online Reporting
1-005.02B1
Immediate Reports of
Diseases, Poisonings, and Organisms: Laboratories must make
immediate reports of diseases, poisonings, and organisms listed in 173 NAC
1-004.01A, both by
telephone to a live public health surveillance official within 24 hours of
diagnosis or detection and by electronic reporting to NEDSS. Reports must
include the information as specified in
1-005.02B4.
See 173 NAC
1-006, Where to Report.
1-005.02B2
Immediate Reports of
Clusters, Outbreaks, or Unusual Events, Including Possible Bioterroristic
Attacks: Laboratories must make immediate reports by telephone to
a live public health surveillance official within 24 hours of diagnosis or
detection, information relating to diagnosed, detected, or suspected clusters,
outbreaks, or epidemics of any health problem, infectious or other,
both in the community and in healthcare settings,
including food poisoning, influenza, or possible bioterroristic attack;
increased disease incidence beyond expectations; unexplained deaths possibly
due to infectious causes; and any unusual disease or manifestations of illness.
Reports must include the information as specified in
1-005.02B4.
1-005.02B3
Reports Within Seven
Days: Laboratories must make reports of diseases, poisonings, and
organisms diagnosed or detected, listed in 173 NAC 1-004.02, collected during
one calendar week. Reports must be submitted no later than the following
Tuesday and must include the information
as specified in
1-005.02B4.
1-005.02B3a For the purposes of reporting
AIDS and HIV, the laboratory reporting requirement applies as follows:
1. Any FDA approved
test or combination of tests indicative of HIV-1 or HIV-2 that has acceptable
specificity and sensitivity to reliably detect HIV infection is
reportable.
2. A laboratory
analyzing samples for any of the tests as listed below must report all of the
following results:
a. Any result
(positive, negative or indeterminate) on a
confirmatory test for HIV antibody , (e.g. Western
blot or immunofluorescence antibody test ), usually
preceded by a positive screening test for HIV antibody,
(e.g. repeatedly reactive enzyme
immunoassay);
b. All quantitative
HIV RNA PCR tests regardless of the result. Include the detailed name of the
test, detection limits of test, and/or interpretation of results. (This applies
only to laboratories performing ELR.);
c. All positive results on any of the
following:
(1) Qualitative HIV nucleic acid
(DNA or RNA) detection [e.g. DNA polymerase chain reaction
];
(2) HIV
p24 antigen test, including neutralization assay;
(3) HIV isolation (viral culture);
and
d. All CD4 counts
per microliter and all CD4 percentages.
1-005.02B4
Report
Information: Reports made under 1-005.02B must contain the following
information:
1.
Patient first and last name;
2.
Patient address including
street, city, and zip;
3.
Patient date of
birth;
4.
Patient gender;
5.
Patient race and ethnicity (if
available);
6.
Patient pregnancy status (if available);
7.
Date of specimen
collection;
8.
Specimen source;
9.
If lead test, whether sample
is a capillary or venous blood sample;
10.
Ordered
test;
11.
Laboratory findings or result;
12.
Physician
name;
13.
Physician address and telephone number.
1-005.02C
Laboratories Using Automated Electronic Laboratory Reporting
(ELR)
1-005.02C1 Required data
fields include:
1. Patient first and last
name;
2. Patient address including
street, city, state, and zip;
3.
Patient date of birth;
4. Patient
sex;
5. Patient ID
number;
6. Performing laboratory's
name, address, and phone number;
7.
Date and time of specimen collection;
8. Date and time the test was
performed;
9. Specimen
source;
10. Type of test
performed;
11. Test
result;
12. Result units;
13. Date and time the test was
verified;
14. Accession
number;
15. Date of report;
and
16. Submitting provider's name,
address, phone number, and office name; and, if available,
17. Pregnancy status;
18. Race/Ethnicity (Hispanic /
Non-Hispanic);
19. Code for ordered
test;
20. Code for test
result;
21. Result flag;
22. High and low result reference
range;
23. Provider ID
number;
24. Provider office ID
number;
25. ELR report date;
and
26. The following data elements
stored in the PV1 segment of HL7:
Element Name |
Sequence |
Patient Class |
2 |
Assigned Patient Location |
3 |
Admission Type |
4 |
Prior Patient Location |
6 |
Attending Doctor |
7
|
Admit Source |
14 |
Admitting Doctor |
17 |
Patient Type |
18 |
Discharge Disposition |
36 |
Discharged to Location |
37 |
Admit Date and Time |
44 |
Discharge Date and Time |
45 |
A laboratory's test results must be screened via an automated
computer algorithm no less than once every 24 hours, and a file or files
meeting this reporting requirement must be forwarded electronically to the
department no less than once every 24 hours. Automated computer screening
algorithms must be validated initially and once each year to ensure the
screening process will capture all reportable disease test results that may be
generated by the reporting laboratory. Results of this validation must be
documented and maintained on file for two years at the laboratory for review by
the department.
Electronic reporting does not exempt the laboratory from
reporting by telephone those diseases that must be reported immediately.
1-005.02C2 Reporting of
Antibiotic Susceptibility Results: Laboratories with automated electronic
reporting capability which perform antibiotic susceptibility testing (AST) for
bacterial diseases listed under 173 NAC
1-004 must report antibiotic
susceptibility results, including minimal inhibitory concentration, for these
tests. This requirement includes traditional broth, agar, and newer automated
methods of AST, as well as molecular-based methods that assay for the molecular
determinants of antibiotic resistance. Reports must include the method used for
AST. Clinical laboratories must report AST results to the DHHS Division of
Public Health via automated ELR. When necessary for the protection of the
public health, the DHHS Division of Public Health may request additional
reporting of AST results on other infectious agents that have increased in
either incidence or severity.
005.03 Healthcare Associated Infections
HAI reports made to NHSN need not be reported separately to
state and local public health departments provided access to NHSN HAI data has
been given to state and local public health departments.